CareSource Foundation Awards Grant to Overdose Lifeline

Updated on May 7, 2022

The CareSource Foundation has awarded Overdose Lifeline, Inc. a more than $178,000 grant to improve the prevention of and response to opioid overdoses in Indiana schools. These funds will provide school partners with the emergency, life-saving medication naloxone, develop a custom training course for school staff and connect schools to evidence-based prevention programs.

“CareSource knows schools are a critical partner in the fight against opioid misuse among young Hoosiers,” said Steve Smitherman, president of CareSource Indiana. “We’re proud to partner with Overdose Lifeline to empower more schools to address this issue head on.”
Under an Indiana 2017 law, school districts are allowed to stock naloxone as an “emergency medication,” just as they are able to stock albuterol for severe asthma and auto-injectable epinephrine for severe allergies. However, few Indiana schools have implemented such a program involving naloxone. The Indiana Department of Health Naloxone entity report lists just two: South Bend Community School Corporation and Jennings County School Corporation.

“The Overdose Lifeline team believes it’s essential for Indiana schools to have staff trained in how to recognize and respond to an overdose emergency,” said Justin Phillips, executive director of Overdose Lifeline, Inc. “Additionally, preventative measures can reduce the number of young people who misuse non-prescribed opioids.”

Over the next three years, Overdose Lifeline, with funding from the CareSource Foundation, plans to increase the number of Indiana schools who have implemented an Opioid Overdose Emergency Preparedness and Response program by 275 schools.

About CareSource

CareSource is a nonprofit, nationally recognized managed care organization with over 2 million members. Headquartered in Dayton, Ohio since its founding in 1989, CareSource administers one of the largest Medicaid managed care plans in the U.S. The organization offers health insurance, including Medicaid, Health Insurance Marketplace, Medicare Advantage and dual-eligible programs.

Through its network of health plans, CareSource serves members in Arkansas, Georgia, Indiana, Kentucky, Ohio and West Virginia. The company is leading the way in serving populations with complex needs and extended its presence into 12 additional states with the acquisition of The Columbus Organization, a trusted partner to health care agencies and provider organizations in improving coordination and support for individuals with intellectual/developmental disabilities and behavioral health challenges through its staffing, quality improvement and care coordination services. As a mission-driven organization, CareSource is transforming health care with innovative programs that address the social determinants of health, health equity, prevention and access to care. For more, visit www.caresource.com, follow @caresource on Twitter, or like CareSource on Facebook.  

About Overdose Lifeline, Inc. 

The mission of Overdose Lifeline (ODL) is to carry the message of HOPE to individuals, families, and communities affected by the disease of addiction and to work toward our vision that there will be a time when the chronic disease of addiction receives the same care and attention as any other chronic disease. We address the challenge of preventable deaths associated with substance misuse/addiction through advocacy, education, harm reduction, prevention, and support in the hope that families will not endure devastating loss associated with misuse and addiction. 

For more, visit overdoselifeline.org.

The Editorial Team at Healthcare Business Today is made up of skilled healthcare writers and experts, led by our managing editor, Daniel Casciato, who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We offer readers access to fresh health, medicine, science, and technology developments and the latest in patient news, emphasizing how these developments affect our lives.